Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.
Kerchberger AM, Sheth AN, Angert CD, Mehta CC, Summers NA, Ofotokun I, Gustafson D, Weiser SD, Sharma A, Adimora AA, French AL, Augenbraun M, Cocohoba J, Kassaye S, Bolivar H, Govindarajulu U, Konkle-Parker D, Golub ET, Lahiri CD. Kerchberger AM, et al. Among authors: ofotokun i. Clin Infect Dis. 2020 Jul 27;71(3):593-600. doi: 10.1093/cid/ciz853. Clin Infect Dis. 2020. PMID: 31504324 Free PMC article.
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study.
Ofotokun I, Sheth AN, Sanford SE, Easley KA, Shenvi N, White K, Eaton ME, Del Rio C, Lennox JL. Ofotokun I, et al. AIDS Res Hum Retroviruses. 2012 Oct;28(10):1196-206. doi: 10.1089/AID.2011.0336. Epub 2012 Apr 20. AIDS Res Hum Retroviruses. 2012. PMID: 22364141 Free PMC article. Clinical Trial.
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.
Ofotokun I, Na LH, Landovitz RJ, Ribaudo HJ, McComsey GA, Godfrey C, Aweeka F, Cohn SE, Sagar M, Kuritzkes DR, Brown TT, Patterson KB, Para MF, Leavitt RY, Villasis-Keever A, Baugh BP, Lennox JL, Currier JS; AIDS Clinical Trials Group (ACTG) A5257 Team. Ofotokun I, et al. Clin Infect Dis. 2015 Jun 15;60(12):1842-51. doi: 10.1093/cid/civ193. Epub 2015 Mar 12. Clin Infect Dis. 2015. PMID: 25767256 Free PMC article. Clinical Trial.
Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women.
Lahiri CD, Dugan KB, Xie X, Reimers L, Burk RD, Anastos K, Massad LS, Eltoum IE, Xue X, DʼSouza G, Flowers L, Palefsky JM, Rahangdale L, Strickler HD, Ofotokun I. Lahiri CD, et al. Among authors: ofotokun i. J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):e63-6. doi: 10.1097/QAI.0000000000000752. J Acquir Immune Defic Syndr. 2015. PMID: 26181819 Free PMC article. No abstract available.
208 results